Clinical Study
High Intensity Focused Ultrasound versus Brachytherapy for the Treatment of Localized Prostate Cancer: A Matched-Pair Analysis
Table 3
Oncologic outcomes for the cohort stratified according to the D’Amico risk classification.
| | Brachytherapy | HIFU | Hazards ratio (CI 95%) |
| Biochemical recurrence-free survival rates | Phoenix definition: 68.5% | Phoenix definition: 53.1% | 0.41 (0.19–0.81) | Stuttgart definition: 60.9% | Stuttgart definition: 51.3% | 0.39 (0.19–0.74) | Low risk | Phoenix definition: 77.5% | Phoenix definition: 68% | 0.31 (0.09–0.94) | Stuttgart definition: 77.5% | Stuttgart definition: 56.3% | 0.31 (0.10–0.84) | Intermediate risk | Phoenix definition: 58.8% | Phoenix definition: 44.9% | 0.47 (0.17–1.13) | Stuttgart definition: 58.8% | Stuttgart definition: 42% | 0.41 (0.15–0.97) | Metastasis-free survival rates | 79.8% | 85% | 1.08 (0.36–2.95) | Cancer specific survival rates | 92% | 89% | 0.67 (0.32–1.29) | Overall survival rates | 97.5% | 88% | 0.24 (0.01–1.34) |
|
|
HIFU: high intensity focused ultrasound; CI: confidence interval.
|